Heart Test Laboratories Inc. Common Stock (HSCS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Heart Test Laboratories Inc. Common Stock (HSCS) has a cash flow conversion efficiency ratio of -558.107x as of October 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.33 Billion) by net assets ($4.18 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See HSCS net asset quality score to measure how much of total assets are equity-financed.
Heart Test Laboratories Inc. Common Stock - Cash Flow Conversion Efficiency Trend (2020–2025)
This chart illustrates how Heart Test Laboratories Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore HSCS operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Heart Test Laboratories Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Heart Test Laboratories Inc. Common Stock ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ssif Broker Cl
RO:BRK
|
2.864x |
|
Solueta Co Ltd
KQ:154040
|
-0.026x |
|
Barunson Entertainment & Arts Corporation
KQ:035620
|
0.014x |
|
Auga Group AB
STU:W9Z
|
0.032x |
|
American Shared Hospital Service
NYSE MKT:AMS
|
0.058x |
|
Cloudastructure, Inc. Class A Common Stock
NASDAQ:CSAI
|
-0.141x |
|
Ayo Technology Solutions Ltd
JSE:AYO
|
-0.173x |
|
Iron Horse Acquisitions Corp. Common Stock
NASDAQ:IROH
|
1.004x |
Annual Cash Flow Conversion Efficiency for Heart Test Laboratories Inc. Common Stock (2020–2025)
The table below shows the annual cash flow conversion efficiency of Heart Test Laboratories Inc. Common Stock from 2020 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Heart Test Laboratories Inc. Common Stoc.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-04-30 | $205.17K | $-7.41 Million | -36.131x | -4255.39% |
| 2024-04-30 | $7.32 Million | $-6.07 Million | -0.830x | +96.69% |
| 2023-04-30 | $230.56K | $-5.77 Million | -25.042x | -4261.43% |
| 2022-04-30 | $-6.06 Million | $-3.64 Million | 0.602x | -53.14% |
| 2021-04-30 | $-1.91 Million | $-2.45 Million | 1.284x | +110.55% |
| 2020-04-30 | $315.55K | $-3.84 Million | -12.169x | -- |
About Heart Test Laboratories Inc. Common Stock
HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting… Read more